Sesen Bio
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
245 1st St Ste 1800, Cambridge, Massachu...Phone Number
(617) 444-8550Website
www.sesenbio.comRevenue
$40 MillionIndustry
About Sesen Bio
Sesen Bio is a clinical-stage biotechnology company focused on developing targeted fusion protein therapeutics for cancer treatment. Founded in 2008, the company specializes in research and development of innovative biological treatments for bladder cancer. Their lead product candidate, Vicineum, is designed to treat non-muscle invasive bladder cancer that has not responded to conventional therapies. Sesen Bio has established strategic partnerships with pharmaceutical companies in various global regions to support commercialization efforts. The company maintains worldwide rights to its technology with specific regional exceptions where it has formed commercial partnerships. Sesen Bio is publicly traded and continues to advance its pipeline of targeted cancer therapeutics through clinical trials and regulatory processes.Explore more
Sesen Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Sesen Bio
Compare insights from companies similar to Sesen Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sesen Bio Tech Stack
A closer look at the technologies used by Sesen Bio
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sesen Bio
Sign Up For FreeTo access detailed company insights
Sesen Bio is a clinical-stage biotechnology company focused on developing targeted fusion protein therapeutics for cancer treatment. Founded in 2008, the company specializes in research and development of innovative biological treatments for bladder cancer. Their lead product candidate, Vicineum, is designed to treat non-muscle invasive bladder can... Read More
